Abstract

TPS2081 Background: Cytotoxic drug delivery to high grade glioma (HGG) is limited by the blood brain barrier (BBB). Convection-enhanced delivery (CED) improves chemotherapy delivery by utilizing fl...

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AT-25 * A PHASE I STUDY OF CONVECTION-ENHANCED DELIVERY OF LIPOSOMAL-IRINOTECAN USING REAL-TIME IMAGING WITH GADOLINIUM IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
S Han ... M Prados
Neuro-Oncology | VOL. 16
S Han, et. al.S Han ... M Prados
01 Nov 2014
A PHASE I STUDY OF CONVECTION-ENHANCED DELIVERY OF LIPOSOMAL-IRINOTECAN USING REAL-TIME IMAGING WITH GADOLINIUM IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
N Butowski ... M Aghi
Neuro-Oncology | VOL. 16
N Butowski, et. al.N Butowski ... M Aghi
01 Jul 2014
Convection-Enhanced Delivery of Nimustine Hydrochloride for Recurrent Spinal Cord High-grade Glioma
Toshiki Endo ... Ryuta Saito
Neurosurgery | VOL. 66
Toshiki Endo, et. al.Toshiki Endo ... Ryuta Saito
20 Aug 2019
Regression of Recurrent Spinal Cord High-Grade Glioma After Convection-Enhanced Delivery of Nimustine Hydrochloride: Case Reports and Literature Review.
Toshiki Endo ... Shinichiro Sugiyama
Operative Neurosurgery | VOL. 18
Toshiki Endo, et. al.Toshiki Endo ... Shinichiro Sugiyama
01 Apr 2020
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Influence of Nucleophosmin ( NPM1 ) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration
Claudia Tregnago ... Martina Pigazzi
Journal of Clinical Oncology | VOL. -
Claudia Tregnago, et. al.Claudia Tregnago ... Martina Pigazzi
02 Dec 2024
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer
Lajos Pusztai ... Kevin M Kalinsky
Journal of Clinical Oncology | VOL. -
Lajos Pusztai, et. al.Lajos Pusztai ... Kevin M Kalinsky
02 Dec 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O 6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)
Thomas Walter ...
Journal of Clinical Oncology | VOL. -
Thomas Walter, et. al.Thomas Walter ...
25 Nov 2024
Using Cure Models for Trial Analysis and Design
Michael L Leblanc
Journal of Clinical Oncology | VOL. -
Michael L LeblancMichael L Leblanc
25 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.